DELRAY BEACH, Fla., April 20, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (Nasdaq:PSID), a leader in next generation patient monitoring and diagnostics, announced today that it has developed a new sample preparation method to help ensure a successful diagnostic system through its ability to improve detection and processing of biological samples for more accurate test results. The Company also intends to expand its diagnostic testing platform to include additional biological testing within the healthcare market, and extend those applications to the homeland security market.
